Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Psilocybin Treatment in Obsessive-Compulsive Disorder: a Preliminary Efficacy Study and Exploratory Investigation of Neural Correlates.


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03356483

Organisation Name: Yale University

Overal Status: Recruiting

Start Date: November 13, 2018

Last Update: May 19, 2021

Lead Sponsor: Yale University

Brief Summary: This study aims to investigate the effects of oral psilocybin on OCD symptomatology and provide the first evidence of the neural mechanism that may mediate psilocybin's purported therapeutic effects on OCD.

Conditions:
  • Obsessive-Compulsive Disorder


Total execution time in seconds: 0.22063708305359